MAR 25, 2015 8:08 AM PDT

Legalizing Marijuana and the New Science of Weed

WRITTEN BY: Judy O'Rourke
More than a year into Colorado's experiment legalizing marijuana, labs testing the plants are able for the first time to take stock of the drug's potency and contaminants -- and openly paint a picture of what's in today's weed.

At the National Meeting & Exposition of the American Chemical Society (ACS), one such lab is presenting trends -- and some surprises -- that its preliminary testing has revealed about the marijuana now on the market.
Marijuana buds are often two to three times as potent as they were 30 years ago.
Three major patterns have emerged over the past few months since Andy LaFrate, PhD, and his lab began testing marijuana samples. Those patterns concern potency, amounts of a substance called CBD, and contaminants in the products.

"As far as potency goes, it's been surprising how strong a lot of the marijuana is," LaFrate says. "We've seen potency values close to 30 percent THC, which is huge." LaFrate is the president and director of research of Charas Scientific, one of eight labs certified by Colorado to do potency testing.

THC is an abbreviation for tetrahydrocannabinol, which is the psychoactive compound in the plant. He explains that three decades ago, THC levels were well below 10 percent. Its content has tripled in some strains because producers have been cross-breeding them over the years to meet user demands for higher potency, he says.

But an unexpected consequence of this breeding has occurred, says LaFrate. Many of the samples his lab has tested have little to no cannabidiol, or CBD. CBD is a lesser known compound in marijuana that is of increasing interest to medical marijuana proponents. Researchers are investigating CBD as a treatment for schizophrenia, Huntington's disease, and Alzheimer's disease. It is also being considered for anxiety and depression. But unlike THC, CBD doesn't get people high -- that's a key trait for many people who are wary of buzz-inducing drugs and for potential medical treatments for children. As for recreational users, the lack of CBD in marijuana means that many of the hundreds of strains they select from could in actuality be very similar chemically, according to LaFrate.

"There's a lot of homogeneity whether you're talking medical or retail level," he says. "One plant might have green leaves and another purple, and the absolute amount of cannabinoids might change, which relates to strength. But the ratio of THC to CBD to other cannabinoids isn't changing a whole lot." That means there might be little difference in how the varieties make you feel, even though some people claim one kind will make you mellow and another will make you alert, LaFrate explains.

As for contamination testing, although Colorado doesn't yet require it, some producers have voluntarily submitted samples to see what's in their products. LaFrate says the results have been surprising. His lab looks for both biological and chemical contaminants, such as pathogenic microbes and solvents.

"It's pretty startling just how dirty a lot of this stuff is," he says. "You'll see a marijuana bud that looks beautiful. And then we run it through a biological assay, and we see that it's covered in fungi."

The lab also finds varying levels of chemical contaminants such as butane, which is used to create marijuana extracts. Contamination isn't necessarily a cause for alarm, but it does signal a need to figure out what levels are safe.

"It's a natural product," LaFrate says. "There's going to be microbial growth on it no matter what you do. So the questions become: What's a safe threshold? And which contaminants do we need to be concerned about?"

In other words, legalizing marijuana has raised a lot of issues that still have to be hammered out. LaFrate, who has been involved with the policy side of Colorado's new marijuana market, as well as the laboratory side, says he expects regulations will continue to evolve as scientists, lawmakers and others learn more about the plant and its products.

[Source: American Chemical Society]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
NOV 06, 2019
Chemistry & Physics
NOV 06, 2019
Radioactive Spill? Self-propelled Microbots to the Rescue
Scientists have been looking for an effective method to clean up radioactive elements in industrial wastewater and accidental spill, to support and boost t...
DEC 01, 2019
Cell & Molecular Biology
DEC 01, 2019
Using CRISPR/Cas9 to Modify Chemical Reactions in Cells
Since the CRISPR gene editor was created, researchers around the world have tweaked and refined the tool to use it in a variety of ways....
DEC 18, 2019
Chemistry & Physics
DEC 18, 2019
Physics in Peril? (Part II) - Lost in the "Darkness"
Not many share the same antagonistic view with Sabine Hossenfelder, the physicist who associates the current awkward state of physical science with theoret...
DEC 22, 2019
Space & Astronomy
DEC 22, 2019
How Astronomers Measure Distances to Stars
Extra stellar systems are so far away from our own that we couldn’t even hope of developing a tape measure long enough to determine how far away they...
JAN 28, 2020
Technology
JAN 28, 2020
Portable device analyzes microbes in the environment
Aquatic microbes often serve as challenge to study, after all, they are too tiny to detect. But, what if there was a device that can swiftly analyze aquati...
FEB 13, 2020
Chemistry & Physics
FEB 13, 2020
Equations for Chaos: A Mathematic Paradox
Equations are ordered, elegant mathematical constructs used to describe specific patterns. Can you imagine some formulas depict the very opposite: chaos an...
Loading Comments...